| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/27/1993 | WO1993009770A1 Bactericidal pharmaceutical composition containing chlorhexidine and eugenol |
| 05/27/1993 | WO1993009769A1 Methods and compositions utilizing pure s(+) isomer fluoxetine |
| 05/27/1993 | WO1993009768A1 Fomentation containing ketorolac |
| 05/27/1993 | WO1993009767A1 Prolonged release diltiazem-based formulation |
| 05/27/1993 | WO1993009765A1 Polymer-based osmotic drug delivery system |
| 05/27/1993 | WO1993009764A1 Combined virustatic antimediator (covam) treatment of common colds |
| 05/27/1993 | WO1993009763A1 Pharmaceutical tablet with pvp having an enhanced drug dissolution rate |
| 05/27/1993 | WO1993009762A2 Method for extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents |
| 05/27/1993 | WO1993009760A2 Dermatological and cosmetic compositions |
| 05/27/1993 | WO1993006812A3 Use of an emulsion to prepare an intravenously administered medicament for treating skin diseases |
| 05/27/1993 | WO1993000100A3 Wound cleanser |
| 05/27/1993 | WO1992018227A3 Stable multiple emulsions |
| 05/27/1993 | CA2123910A1 Dermatological and cosmetic compositions |
| 05/27/1993 | CA2123709A1 Lactobacillus and skim milk compositions and methods for preventing microbial urogenital infections |
| 05/27/1993 | CA2123585A1 Polar lipidic composition from plants |
| 05/27/1993 | CA2123494A1 Method and apparatus for partial liquid ventilation using fluorocarbons |
| 05/27/1993 | CA2123487A1 Adhesive hydrogels having extended use lives and process for the preparation of same |
| 05/27/1993 | CA2123486A1 Method for extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents |
| 05/27/1993 | CA2123109A1 Ketorolac-containing fomentation |
| 05/27/1993 | CA2122719A1 Combined virustatic antimediator (covam) treatment of common colds |
| 05/27/1993 | CA2121681A1 Gel particle contrast media for improved diagnostic imaging |
| 05/27/1993 | CA2121502A1 Emulsions containing alkyl-or alkylglycerophosphoryl choline surfactants and methods of use |
| 05/27/1993 | CA2116123A1 Pressure-sensitive poly(n-vinyl lactam) adhesive composition and method for producing and using same |
| 05/27/1993 | CA2100466A1 Unbuffered premixed ranitidine formulation |
| 05/26/1993 | EP0543653A1 Dipyridamole for the treatment of proliferative diseases |
| 05/26/1993 | EP0543572A1 Method for entrapment of active materials in chitosan |
| 05/26/1993 | EP0543541A1 Controlled release flutamide composition |
| 05/26/1993 | EP0543521A2 High dosage topical forms of collagenase |
| 05/26/1993 | EP0543454A2 Encapsulated particles useful as contrast agents in ultrasound and X-ray imaging compositions and methods |
| 05/26/1993 | EP0542979A1 Therapeutic composition for sustained release of magnesium |
| 05/26/1993 | EP0542977A1 Oral composition based on an antibiotic material and clay |
| 05/26/1993 | EP0542930A1 Oral pharmaceutical compositions containing melatonin. |
| 05/26/1993 | EP0542915A1 Multiple drug delivery system |
| 05/26/1993 | EP0542879A1 Process for formulating a solid oral dosage form of loperamide compounds |
| 05/26/1993 | EP0542864A1 Treatment for hypercholesterolemia. |
| 05/26/1993 | EP0542855A1 Microcapsules having a combined atelocollagen/polyholoside wall coagulated by a divalent cation. |
| 05/26/1993 | EP0532703A4 Process for preparing microemulsion |
| 05/26/1993 | EP0527891A4 Biodegradable polyesters for sustained drug delivery |
| 05/26/1993 | EP0435915B1 Compositions for the treatment of leishmaniasis |
| 05/26/1993 | CN1072340A Fatty acid compound biological anticarcinogen |
| 05/26/1993 | CN1072338A Pharmaceutical compositions for oral use and method of preparing them |
| 05/26/1993 | CN1020897C Process for preparing of pentamidine salts useful in treatment and prophylaxis of pneumocystis carinii pneumonia |
| 05/26/1993 | CN1020854C Method for production of musk rheumatic tablets |
| 05/26/1993 | CN1020852C New pharmaceutical preparation for oral use |
| 05/26/1993 | CN1020851C Controlled release delivery system for macromolecules |
| 05/26/1993 | CA2083553A1 Immunogen composition |
| 05/25/1993 | US5214202 Method for preparing benzoic acid derivatives |
| 05/25/1993 | US5214067 Fungicidal compositions and method |
| 05/25/1993 | US5214052 Method for dissolving arginineamides and pharmaceutical compositions containing them |
| 05/25/1993 | US5214040 Side effect reduction |
| 05/25/1993 | US5213818 Device for taking and conveying tablets coming out of a rotary tabletting machine |
| 05/25/1993 | US5213812 Mixing with biodegradable polymer, suspension in gel, microspheres, solvent-free |
| 05/25/1993 | US5213811 Oral sustained-release drug compositions |
| 05/25/1993 | US5213810 Stable compositions for parenteral administration and method of making same |
| 05/25/1993 | US5213809 Delivery system comprising means for controlling internal pressure |
| 05/25/1993 | US5213808 Controlled release article with pulsatile release |
| 05/25/1993 | US5213807 Pharmaceutical composition containing ibuprofen and a prostaglandin |
| 05/25/1993 | US5213806 And cellulose derivative, laxative, antidiarrhea agent |
| 05/25/1993 | US5213805 Lipid vesicles having n,n-dimethylamide derivatives as their primary lipid |
| 05/25/1993 | US5213804 Localized delivery of antibiotic to tumor via bloodstream, encapsulation in liposome |
| 05/25/1993 | US5213803 Consists of monovalent anions, anionic and nonionic detergents , antimicrobial agents, flavors, sweetening and /or flavoring agents; used for killing envelop virus in vitro causing AIDS and Herpes infections |
| 05/25/1993 | US5213802 Pharmaceutical formulations employing esterified alkoxylated polyols as vehicles |
| 05/25/1993 | US5213794 Antacid preparation having a prolonged gastric residence time |
| 05/25/1993 | US5213791 Hydroxylamine or aminoacetic acid or its derivatives |
| 05/25/1993 | US5213738 Filling cavities with blends, leveling and clearing the walls, then compression |
| 05/25/1993 | CA1318172C Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic, vascular, cardiovascular, and/or thrombotic diseases |
| 05/22/1993 | CA2083223A1 Local delivery of dipyridamole for the treatment of proliferative diseases |
| 05/22/1993 | CA2083109A1 Encapsulated particles useful as contrast agents in ultrasound and x-ray imaging compositions and methods |
| 05/21/1993 | CA2083296A1 Composition of matter |
| 05/21/1993 | CA2082352A1 Method for entrapment of active materials in chitosan |
| 05/19/1993 | EP0542364A1 Controlled release device |
| 05/19/1993 | EP0542314A1 Formation of protein microparticles by antisolvent precipitation |
| 05/19/1993 | EP0542299A2 Ester linkage containing polymers for use in pharmaceutical preparations |
| 05/19/1993 | EP0541874A1 Compositions containing diosmin |
| 05/19/1993 | EP0541830A1 Absorption base containing sucrose ester |
| 05/19/1993 | EP0478671B1 Neurological therapy system |
| 05/19/1993 | DE4238263A1 Adhesive comprising hydrogel and crosslinked polyvinyl:lactam - is used in electrodes for biomedical application providing low impedance and good mechanical properties when water and/or moisture is absorbed from skin |
| 05/19/1993 | CN1072093A Nitroglycerine adhesive plaster and process for preparing same |
| 05/19/1993 | CN1072086A Preparing method of cover biomembrane for wound of burn and scald |
| 05/19/1993 | CN1072061A Stable antimicrobial dialdehyde composition and methods of use |
| 05/18/1993 | US5212199 Sorbitan esters as skin permeation enhancers |
| 05/18/1993 | US5212162 Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
| 05/18/1993 | US5211961 Composition, and method, for premilking udder hygiene |
| 05/18/1993 | US5211959 Processes for producing slow-release powders |
| 05/18/1993 | US5211958 Tetracycline with cellulose derivatives as thickeners and tablets |
| 05/18/1993 | US5211957 Diclofenac |
| 05/18/1993 | US5211955 Pharmaceutical composition containing a hydrophilic active compound, treated with an organic acid and encapsulated in a liposome |
| 05/18/1993 | US5211954 Low dose temazepam |
| 05/18/1993 | US5211952 Contraceptive methods and formulations for use therein |
| 05/18/1993 | US5211951 Drug delivery |
| 05/18/1993 | US5211950 Stabilized calcitonin pharmaceutical composition |
| 05/18/1993 | US5211943 Pharmaceutical preparation for administration by percutaneous absorption and a method for their manufacture |
| 05/18/1993 | US5211643 Tow solutions |
| 05/18/1993 | US5211559 Dental treatment tray for holding medicament gel |
| 05/18/1993 | CA1318078C Ion exchange resins loaded with quinolonecarboxylic acid derivatives, their preparation and use |
| 05/18/1993 | CA1317883C Liquid dosage form for oral administration of a pharmaceutically active substance |
| 05/18/1993 | CA1317882C Gelatin coated caplets and process for making same |
| 05/18/1993 | CA1317881C Aerosol compositions for nasal delivery of vitamin b__ |
| 05/18/1993 | CA1317879C Electrolytic transdermal delivery of polypeptides |
| 05/16/1993 | WO1993009783A1 Anti-inflammatory and analgesic plaster |